Market OverviewGenetic testing is guiding personalized treatment approaches for complement 3 glomerulopathy by identifying specific complement regulatory gene mutations that drive disease pathogenesis in individual patients, enabling targeted therapy selection and family counseling for this genetically heterogeneous rare kidney disease. CFH, CFI, MCP, C3, and CFB gene variants are implicated in...
Bangla